@xconomy.com 5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com 5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com 5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push